Plague vaccine
A vaccine, the technology of Yersinia pestis, applied in the field of plague vaccines, can solve the problem that the vaccine is not safe enough to effectively fight against bubonic plague and pneumonic plague, and achieve the effect of convenient vaccination activities, easy manufacture, and rapid protection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0244] We produced a Yersinia pseudotuberculosis strain that is both avirulent and genetically determined for use as a vaccine against plague. To this end, we irreversibly attenuated Yersinia pseudotuberculosis IP32953 strain by deleting genes encoding three important virulence factors (high pathogenicity island, YopK, and pH6Ag / PsaA).
[0245] We cloned the caf operon encoding Yersinia pestis F1 in a plasmid and introduced it into an attenuated Y. pseudotuberculosis strain to generate an encapsulated derivative of the attenuated Y. pseudotuberculosis strain. The resulting strain, designated V674pF1(1), produced F1 capsules in vitro and in vivo. Oral inoculation of V674pF1 allowed intestinal colonization without causing lesions in Peyer's patches and spleen. Vaccination with V674pF1 induced the humoral and cellular components of immunity at the systemic (IgG and Th1 cells) and mucosal level (IgA and Th17 cells). Single oral dose (10 8 CFU) protected 100% of animals against ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com